These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 38343494)

  • 1. Prevalence and Associated Factors of Chronic Obstructive Pulmonary Disease Among Adults in Neno District, Malawi: A Cross-Sectional Analytical Study.
    Zaniku HR; Connolly E; Aron MB; Matanje BL; Ndambo MK; Complex Talama G; Munyaneza F; Ruderman T; Rylance J; Dullie LW; Lalitha R; Banda NPK; Muula AS
    Int J Chron Obstruct Pulmon Dis; 2024; 19():389-401. PubMed ID: 38343494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of chronic obstructive pulmonary disease (COPD) and its associated factors among adults in Abeshge District, Ethiopia: a cross sectional study.
    Woldeamanuel GG; Mingude AB; Geta TG
    BMC Pulm Med; 2019 Oct; 19(1):181. PubMed ID: 31623601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study.
    Wang C; Xu J; Yang L; Xu Y; Zhang X; Bai C; Kang J; Ran P; Shen H; Wen F; Huang K; Yao W; Sun T; Shan G; Yang T; Lin Y; Wu S; Zhu J; Wang R; Shi Z; Zhao J; Ye X; Song Y; Wang Q; Zhou Y; Ding L; Yang T; Chen Y; Guo Y; Xiao F; Lu Y; Peng X; Zhang B; Xiao D; Chen CS; Wang Z; Zhang H; Bu X; Zhang X; An L; Zhang S; Cao Z; Zhan Q; Yang Y; Cao B; Dai H; Liang L; He J;
    Lancet; 2018 Apr; 391(10131):1706-1717. PubMed ID: 29650248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Prevalence of Chronic Obstructive Pulmonary Disease (COPD) and the Heterogeneity of Risk Factors in the Canadian Population: Results from the Canadian Obstructive Lung Disease (COLD) Study.
    Leung C; Bourbeau J; Sin DD; Aaron SD; FitzGerald JM; Maltais F; Marciniuk DD; O'Donnell D; Hernandez P; Chapman KR; Walker B; Road JD; Zheng L; Zou C; Hogg JC; Tan WC;
    Int J Chron Obstruct Pulmon Dis; 2021; 16():305-320. PubMed ID: 33603357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic Obstructive Pulmonary Disease Prevalence and Associated Factors in a Setting of Well-Controlled HIV, A Cross-Sectional Study.
    Kayongo A; Wosu AC; Naz T; Nassali F; Kalyesubula R; Kirenga B; Wise RA; Siddharthan T; Checkley W
    COPD; 2020 Jun; 17(3):297-305. PubMed ID: 32462945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV Infection, Pulmonary Tuberculosis, and COPD in Rural Uganda: A Cross-Sectional Study.
    North CM; Allen JG; Okello S; Sentongo R; Kakuhikire B; Ryan ET; Tsai AC; Christiani DC; Siedner MJ
    Lung; 2018 Feb; 196(1):49-57. PubMed ID: 29260309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of chronic obstructive pulmonary disease among smokers attending primary healthcare clinics in Saudi Arabia.
    Al Ghobain M; Al-Hajjaj MS; Wali SO
    Ann Saudi Med; 2011; 31(2):129-33. PubMed ID: 21403413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of Chronic Obstructive Pulmonary Disease and its Associated Factors in Nepal: Findings from a Community-based Household Survey.
    Adhikari TB; Acharya P; Högman M; Neupane D; Karki A; Drews A; Cooper BG; Sigsgaard T; Kallestrup P
    Int J Chron Obstruct Pulmon Dis; 2020; 15():2319-2331. PubMed ID: 33061350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimating prevalence of chronic obstructive pulmonary disease in the Southern Cone of Latin America: how different spirometric criteria may affect disease burden and health policies.
    Sobrino E; Irazola VE; Gutierrez L; Chen CS; Lanas F; Calandrelli M; Ponzo J; Mores N; Serón P; Lee A; He J; Rubinstein AL
    BMC Pulm Med; 2017 Dec; 17(1):187. PubMed ID: 29228947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence, risk factors and clinical correlates of COPD in a rural setting in Tanzania.
    Magitta NF; Walker RW; Apte KK; Shimwela MD; Mwaiselage JD; Sanga AA; Namdeo AK; Madas SJ; Salvi SS
    Eur Respir J; 2018 Feb; 51(2):. PubMed ID: 29386343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined Forced Expiratory Volume in 1 Second and Forced Vital Capacity Bronchodilator Response, Exacerbations, and Mortality in Chronic Obstructive Pulmonary Disease.
    Fortis S; Comellas A; Make BJ; Hersh CP; Bodduluri S; Georgopoulos D; Kim V; Criner GJ; Dransfield MT; Bhatt SP;
    Ann Am Thorac Soc; 2019 Jul; 16(7):826-835. PubMed ID: 30908927
    [No Abstract]   [Full Text] [Related]  

  • 12. Prevalence of chronic obstructive pulmonary disease and variation in risk factors across four geographically diverse resource-limited settings in Peru.
    Jaganath D; Miranda JJ; Gilman RH; Wise RA; Diette GB; Miele CH; Bernabe-Ortiz A; Checkley W;
    Respir Res; 2015 Mar; 16(1):40. PubMed ID: 25889777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors Associated with Chronic Obstructive Pulmonary Diseases in Nepal: Evidence from a Nationally Representative Population-Based Study.
    Karki KB; Poudyal A; Shrestha N; Mahato NK; Aryal KK; Sijapati MJ; Bista B; Gautam N; Subedi R; Siddiquee NKA; Gyanwali P; Kuch U; Groneberg DA; Jha AK; Dhimal M
    Int J Chron Obstruct Pulmon Dis; 2021; 16():1109-1118. PubMed ID: 33907397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prevalence of chronic obstructive pulmonary disease in Uppsala, Sweden--the Burden of Obstructive Lung Disease (BOLD) study: cross-sectional population-based study.
    Danielsson P; Ólafsdóttir IS; Benediktsdóttir B; Gíslason T; Janson C
    Clin Respir J; 2012 Apr; 6(2):120-7. PubMed ID: 21651748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of chronic obstructive pulmonary disease and associated risk factors in Uganda (FRESH AIR Uganda): a prospective cross-sectional observational study.
    van Gemert F; Kirenga B; Chavannes N; Kamya M; Luzige S; Musinguzi P; Turyagaruka J; Jones R; Tsiligianni I; Williams S; de Jong C; van der Molen T
    Lancet Glob Health; 2015 Jan; 3(1):e44-51. PubMed ID: 25539969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and predictors of airflow obstruction in an HIV tertiary care clinic in Montreal, Canada: a cross-sectional study.
    Costiniuk CT; Nitulescu R; Saneei Z; Wasef N; Salahuddin S; Wasef D; Young J; de Castro C; Routy JP; Lebouché B; Cox J; Smith BM; Ambroise S; Pexos C; Patel M; Szabo J; Haraoui LP; de Pokomandy A; Tsoukas C; Falutz J; LeBlanc R; Giannakis A; Frenette C; Jenabian MA; Bourbeau J; Klein MB
    HIV Med; 2019 Mar; 20(3):192-201. PubMed ID: 30620136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between socioeconomic status and chronic obstructive pulmonary disease in Jiangsu province, China: a population-based study.
    Zhang DD; Liu JN; Ye Q; Chen Z; Wu L; Peng XQ; Lu G; Zhou JY; Tao R; Ding Z; Xu F; Zhou L
    Chin Med J (Engl); 2021 Jun; 134(13):1552-1560. PubMed ID: 34250960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and correlates of chronic obstructive pulmonary disease and chronic respiratory symptoms in rural southwestern Uganda: a cross-sectional, population-based study.
    North CM; Kakuhikire B; Vořechovská D; Hausammann-Kigozi S; McDonough AQ; Downey J; Christiani DC; Tsai AC; Siedner MJ
    J Glob Health; 2019 Jun; 9(1):010434. PubMed ID: 31217961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic Airflow Obstruction in a Black African Population: Results of BOLD Study, Ile-Ife, Nigeria.
    Obaseki DO; Erhabor GE; Gnatiuc L; Adewole OO; Buist SA; Burney PG
    COPD; 2016; 13(1):42-9. PubMed ID: 26451840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic obstructive pulmonary disease: an emerging comorbidity in HIV-infected patients in the HAART era?
    Madeddu G; Fois AG; Calia GM; Babudieri S; Soddu V; Becciu F; Fiori ML; Spada V; Lovigu C; Mannazzu M; Caddeo A; Piras B; Pirina P; Mura MS
    Infection; 2013 Apr; 41(2):347-53. PubMed ID: 22971938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.